MacroGenics
MGNX
#8653
Rank
S$0.30 B
Marketcap
S$4.77
Share price
-7.73%
Change (1 day)
123.13%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of March 2026 : S$0.19 Billion

According to MacroGenics's latest financial reports the company has S$0.19 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$0.24 B-11.05%
2024-12-31S$0.27 B-9.68%
2023-12-31S$0.30 B46.68%
2022-12-31S$0.20 B-37.17%
2021-12-31S$0.32 B-8.65%
2020-12-31S$0.36 B23.95%
2019-12-31S$0.29 B-8.57%
2018-12-31S$0.31 B-22.05%
2017-12-31S$0.40 B1.8%
2016-12-31S$0.40 B-16.41%
2015-12-31S$0.47 B130.32%
2014-12-31S$0.20 B41.1%
2013-12-31S$0.14 B152.77%
2012-12-31S$58.38 M-18.35%
2011-12-31S$71.51 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
S$16.86 B 8,377.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$6.81 B 3,324.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$15.52 B 7,705.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$9.85 B 4,855.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$7.35 B 3,597.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$13.52 B 6,698.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.57 B 188.50%๐Ÿ‡บ๐Ÿ‡ธ USA